Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apricoxib + Erlotinib in Advanced NSCLC
NCT00652340Phase 2Completed
- Sponsor
- Adastra Pharmaceuticals
- Start
- Apr 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apricoxib in non-small cell lung cancer (NSCLC), sponsored by Adastra Pharmaceuticals. Started Apr 2008; status: completed.
02
Drugs
apricoxib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00652340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652340.